Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis.

Oncogene
Z-H WenX-C Bai

Abstract

The mammalian target of rapamycin (mTOR) signaling pathway is upregulated in the pathogenesis of many cancers. Arachidonic acid (AA) and its metabolites play critical role in the development of breast cancer, but the mechanisms through which AA promotes mammary tumorigenesis and progression are poorly understood. We found that the levels of AA and cytosolic phospholipase A2 (cPLA2) strongly correlated with the signaling activity of mTORC1 and mTORC2 as well as the expression levels of vascular epithelial growth factor (VEGF) in human breast tumor tissues. In cultured breast cancer cells, AA effectively activated both mTOR complex 1 (mTORC1) and mTORC2. Interestingly, AA-stimulated mTORC1 activation was independent of amino acids, phosphatidylinositol 3-kinase (PI3-K) and tuberous sclerosis complex 2 (TSC2), which suggests a novel mechanism for mTORC1 activation. Further studies revealed that AA stimulated mTORC1 activity through destabilization of mTOR-raptor association in ras homolog enriched in brain (Rheb)-dependent mechanism. Moreover, we showed that AA-stimulated cell proliferation and angiogenesis required mTOR activity and that the effect of AA was mediated by lipoxygenase (LOX) but not cyclooxygenase-2 (COX-2). In anim...Continue Reading

References

Mar 17, 1999·JAMA : the Journal of the American Medical Association·M D HolmesW C Willett
Oct 7, 2004·Nature Cell Biology·Estela JacintoMichael N Hall
Dec 21, 2005·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Wen G JiangRobert E Mansel
Feb 24, 2006·Nature Reviews. Cancer·Cornelia M UlrichJohn D Potter
Apr 11, 2006·Molecular Cell·Dos D SarbassovDavid M Sabatini
Aug 11, 2006·Journal of Mammary Gland Biology and Neoplasia·Nancy E Hynes, Anne Boulay
Oct 21, 2006·Biochimica Et Biophysica Acta·Masako Nakanishi, Daniel W Rosenberg
Jul 7, 2007·Cancer Cell·David A Guertin, David M Sabatini
Jul 13, 2007·Breast Cancer Research and Treatment·Gurpreet Singh-RangerKefah Mokbel
Oct 19, 2007·Cancer Metastasis Reviews·Graham P PidgeonKenneth V Honn
Jan 16, 2008·International Journal of Clinical Practice·A Agrawal, I S Fentiman
May 24, 2008·Science·Yasemin SancakDavid M Sabatini
Sep 9, 2008·Trends in Molecular Medicine·Hedi HariziNorbert Gualde
Sep 23, 2008·Experimental Cell Research·Napoleon Navarro-TitoEduardo Perez Salazar
Nov 28, 2008·International Journal of Cancer. Journal International Du Cancer·Anne C M ThiébautFrançoise Clavel-Chapelon
Feb 26, 2009·International Immunopharmacology·C A C Hyde, S Missailidis
May 5, 2009·Expert Opinion on Therapeutic Targets·Leora HornDavid H Johnson
Oct 14, 2009·Cellular and Molecular Life Sciences : CMLS·Xiaochun Bai, Yu Jiang
Nov 26, 2009·The International Journal of Biochemistry & Cell Biology·Napoleon Navarro-TitoEduardo Perez Salazar
Dec 1, 2009·Current Opinion in Cell Biology·Alejo Efeyan, David M Sabatini
Mar 9, 2010·European Journal of Cell Biology·Raul Martinez-OrozcoEduardo Perez Salazar
Mar 17, 2010·The Journal of Biological Chemistry·Kathryn G Foster, Diane C Fingar
Apr 15, 2010·Current Pharmaceutical Design·Cecilia MennaAntonio Procopio
Jul 8, 2010·Trends in Molecular Medicine·Virginie Mieulet, Richard F Lamb
Aug 24, 2010·Journal of the National Cancer Institute·Amanda G LinkousDennis E Hallahan
Oct 23, 2010·Molecular Cell·Shomit SenguptaDavid M Sabatini
Dec 16, 2010·Nature Reviews. Molecular Cell Biology·Roberto ZoncuDavid M Sabatini
Feb 9, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Jessica L Yecies, Brendan D Manning

❮ Previous
Next ❯

Citations

Jul 20, 2012·International Journal of Breast Cancer·Benoît Chénais, Vincent Blanckaert
Mar 2, 2013·Breast Cancer Research : BCR·Siver A MoestueGeir Bjørkøy
Oct 19, 2013·International Journal of Molecular Sciences·Amanda VillalvillaGabriel Herrero-Beaumont
Oct 16, 2015·Journal of Receptor and Signal Transduction Research·Shuang WangDaling Zhu
Feb 6, 2016·Annals of Dermatology·Semchin MunkhbayarOhsang Kwon
May 6, 2015·Breast Cancer Research : BCR·Carol J FabianStephen D Hursting
May 6, 2014·Frontiers in Molecular Neuroscience·Catherine J FricanoBryan W Luikart
Feb 19, 2013·Oncogene·A RufiniG Melino
Jan 15, 2015·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·U HeilmeierT M Link
Dec 20, 2018·Journal of Cheminformatics·Ling LuoHongfei Lin
Aug 12, 2014·Oncology Reports·Yuichi KinoshitaAiro Tsubura
Feb 13, 2018·Experimental and Therapeutic Medicine·Oana ZanoagaIoana Berindan-Neagoe
Jan 13, 2018·International Journal of Molecular Sciences·Francesco Moccia
Jan 1, 2014·Dermato-endocrinology·Jina Jy Kum, Zia A Khan
Aug 31, 2018·Analytical Cellular Pathology (Amsterdam)·Jenefa L Canoy, Jayzon G Bitacura
May 4, 2017·Proceedings of the National Academy of Sciences of the United States of America·Yu-Jun DaiSai-Juan Chen
Oct 2, 2019·International Journal of Molecular Sciences·Hanna Maja TunsetSiver Andreas Moestue
May 29, 2014·Cancer Prevention Research·Hang ZhengLiping Wang
Jan 5, 2021·Journal of Biochemical and Molecular Toxicology·Shreetama BandyopadhayayaChandi C Mandal
Apr 6, 2021·Frontiers in Endocrinology·Ximena M Bustamante-MarinDelisha A Stewart

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.